Vimarsana
Biggest News Aggregation in the World

Sergio Calvo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sergio Calvo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sergio Calvo Today - Breaking & Trending Today

Europatat unveils final program and speakers for 2024 Congress - Vimarsana News

Europatat unveils final program and speakers for 2024 Congress

Europatat has announce the final program and distinguished speakers for its upcoming annual event, the Europatat Congress.

Canadian Nuclear Laboratories and Jubilant Radiopharma to collaborate on development of novel alpha radiopharmaceuticals - Vimarsana News

Canadian Nuclear Laboratories and Jubilant Radiopharma to collaborate on development of novel alpha radiopharmaceuticals

CHALK RIVER — Canadian Nuclear Laboratories (CNL) recently announced that it will collaborate with Jubilant Radiopharma, an international leader in…

Canadian Nuclear Laboratories and Jubilant Radiopharma to Collaborate on the Development of Novel Alpha Radiopharmaceuticals - Vimarsana News

Canadian Nuclear Laboratories and Jubilant Radiopharma to Collaborate on the Development of Novel Alpha Radiopharmaceuticals

Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, is pleased to announce that it will collaborate with Jubilant

Canadian Nuclear Laboratories and Jubilant Radiopharma to Collaborate on the Development of ... - Vimarsana News

Canadian Nuclear Laboratories and Jubilant Radiopharma to Collaborate on the Development of ...

CHALK RIVER, Ontario, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, is pleased to announce that it will collaborate with Jubilant

Jubilant Pharmova gains after subsidiary wins over Bracco's legal appeals in US court - Vimarsana News

Jubilant Pharmova gains after subsidiary wins over Bracco's legal appeals in US court

Jubilant Pharmova rose 1.70% to Rs 849.70 after the company said its subsidiary, Jubilant Pharma, received a favorable and unanimous judgment from the US Court of Appeals.Jubilant Pharma, a subsidiary of Jubilant Pharmova, announced that it has received a favorable and unanimous judgment from the United States Court of Appeals summarily affirming Jubilant's earlier favorable rulings from the US Patent Office ("PTAB") and the US International Trade Commission ("ITC"). These two rulings by the Appellate Court deny the appeals filed by Bracco Diagnostics, Inc. Jubilant successfully challenged Br...